The {pharmaceutical industry is rapidly exploring novel treatment strategies for obesity , and the arrival of semaglutide 10mg doses represents a advancement . Clinicians are cautiously assess the potential benefits and risks associated with this higher strength version , particularly in contrast with existing lower-dose semaglutide products . More